clinical trial · NCT06888193
A Study to Assess the Concentration of Bimekizumab in Mature Breast Milk From Mothers Receiving Treatment With Bimzelx® (Bimekizumab)
UCB Biopharma SRL·phase1·recruiting·n = 20
Moderate to Severe Plaque PsoriasisPsoriatic ArthritisAxial SpondyloarthritisHidradenitis SuppurativaBimekizumab
brief summary
Primary purpose of the study is to assess the concentration of bimekizumab in mature human breast milk.
started
Nov 5, 2025
primary completion
Dec 31, 2027
completion
Dec 31, 2027
last updated
Sep 18, 2026
official title
A Multicenter Open-label, Prospective Study to Assess the Concentration of Bimekizumab in Mature Breast Milk From Mothers Receiving Treatment With Bimzelx® (Bimekizumab)
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol